What does DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK do?

DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK is a general practice in Jabbeke. Private Limited, started on 1 February 2008.

What is the address of DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK?

The registered office of DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK is located at Hagebos 29, 8490 Jabbeke.

Is DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK still active?

Yes. According to the CBE (2 November 2026) DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK is active, legal situation “Normale toestand”, started on 1 February 2008.

Is DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK registered on Peppol?

Yes, DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK is registered on the Peppol network with ID 0208:0895447778.

What is the enterprise number of DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK?

The enterprise number of DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK is BE0895447778.

When was DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK founded?

DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK was founded on 1 February 2008.

Who are the directors of DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK?

According to the 2025 annual accounts, the directors of DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK are: Dany Verstraete.

Is DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 February 2008; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK make in 2025?

DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK posted a profit after taxes of € 64,746 in financial year 2025.

What is the revenue of DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK?

As a small company, DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 105,314.

DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK (Private Limited)

Dossier DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK, printed on 2 November 2026 from databakkes.be/en/0895447778/dr-dany-verstraete-huisartsenpraktijk. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK from Jabbeke, company number BE0895447778, closed financial year 2025 with a result of € 64,746 after tax. For that financial year DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK recorded a gross margin of € 105,314 and equity of € 309,482. Compared with financial year 2024, the result moved from € 51,727 to € 64,746. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.

What it is worth Growing

€ 309,482

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 64,746

▲ 25% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 20,361

▼ 25% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 59,901 paid out

93 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 48,699

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,680

▼ 32% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 480

▼ 62% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 74,222 Gross margin 2022: € 74,222 First fiscal year in the series	€ 81,696 Gross margin 2023: € 81,696 ▲ 10% vs 2022 (€ 74,222) Favourable step	€ 78,060 Gross margin 2024: € 78,060 ▼ 4% vs 2023 (€ 81,696) Unfavourable step	€ 105,314 Gross margin 2025: € 105,314 ▲ 35% vs 2024 (€ 78,060) Favourable step	▲ 35%
Profit after taxes	€ 48,627 Profit after taxes 2022: € 48,627 First fiscal year in the series	€ 53,265 Profit after taxes 2023: € 53,265 ▲ 10% vs 2022 (€ 48,627) Favourable step	€ 51,727 Profit after taxes 2024: € 51,727 ▼ 3% vs 2023 (€ 53,265) Unfavourable step	€ 64,746 Profit after taxes 2025: € 64,746 ▲ 25% vs 2024 (€ 51,727) Favourable step	▲ 25%
Equity	€ 202,978 Equity 2022: € 202,978 First fiscal year in the series	€ 254,576 Equity 2023: € 254,576 ▲ 25% vs 2022 (€ 202,978) Favourable step	€ 304,637 Equity 2024: € 304,637 ▲ 20% vs 2023 (€ 254,576) Favourable step	€ 309,482 Equity 2025: € 309,482 ▲ 2% vs 2024 (€ 304,637) Favourable step	▲ 2%
Total debts	€ 6,290 Total debts 2022: € 6,290 First fiscal year in the series	€ 9,862 Total debts 2023: € 9,862 ▲ 57% vs 2022 (€ 6,290) Unfavourable step	€ 7,227 Total debts 2024: € 7,227 ▼ 27% vs 2023 (€ 9,862) Favourable step	€ 32,271 Total debts 2025: € 32,271 ▲ € 25,044 vs 2024 (€ 7,227) Unfavourable step	▲ € 25,044
Cash	€ 126,453 Cash 2022: € 126,453 First fiscal year in the series	€ 101,798 Cash 2023: € 101,798 ▼ 19% vs 2022 (€ 126,453) Unfavourable step	€ 27,317 Cash 2024: € 27,317 ▼ 73% vs 2023 (€ 101,798) Unfavourable step	€ 20,361 Cash 2025: € 20,361 ▼ 25% vs 2024 (€ 27,317) Unfavourable step	▼ 25%
Retained profit	€ 190,578 Retained profit 2022: € 190,578 First fiscal year in the series	€ 242,176 Retained profit 2023: € 242,176 ▲ 27% vs 2022 (€ 190,578) Favourable step	€ 292,237 Retained profit 2024: € 292,237 ▲ 21% vs 2023 (€ 242,176) Favourable step	€ 297,082 Retained profit 2025: € 297,082 ▲ 2% vs 2024 (€ 292,237) Favourable step	▲ 2%
Dividend	€ 1,600 Dividend 2022: € 1,600 First fiscal year in the series	€ 1,666 Dividend 2023: € 1,666 ▲ 4% vs 2022 (€ 1,600) Unchanged	€ 1,666 Dividend 2024: € 1,666 Unchanged (€ 1,666) Unchanged	€ 59,901 Dividend 2025: € 59,901 ▲ € 58,235 vs 2024 (€ 1,666) Unchanged	▲ € 58,235
Balance sheet total	€ 209,267 Balance sheet total 2022: € 209,267 First fiscal year in the series	€ 264,438 Balance sheet total 2023: € 264,438 ▲ 26% vs 2022 (€ 209,267) Unchanged	€ 311,864 Balance sheet total 2024: € 311,864 ▲ 18% vs 2023 (€ 264,438) Unchanged	€ 341,753 Balance sheet total 2025: € 341,753 ▲ 10% vs 2024 (€ 311,864) Unchanged	▲ 10%

Key figures of DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK?

What happened at DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 8, 2026 New annual accounts for financial year 2025: profit of € 64,746 (▲ 25% vs 2024). Source: NBB ↗
Feb 1, 2008 Start of the company according to the CBE. KBO

In short

From € 48,627 profit in 2022 to € 64,746 profit in 2025.

Paid € 108,886 in corporate taxes since 2022.

Best year ever: 2025, with € 64,746 profit.

Paid out € 64,833 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Dany Verstraete

DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK

Behind DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK is Dany Verstraete.

Directors

According to the 2025 annual accounts

Dany Verstraete

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Hagebos 29

8490 Jabbeke

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0895.447.778
VAT number: BE 0895.447.778
Registered office: Hagebos 29, 8490 Jabbeke
Names & denominations: DR. DANY VERSTRAETE-HUISARTSENPRAKTIJK
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 February 2008
Peppol: Active · Active since 21 Nov 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗